Search clinical trials for: Intermediate dose enoxaparin

Total 6747 results

Damascus University

Completed

Effect of Laser Application in Pain Management Following the Use of Orthodontic Elastomeric Separators

Orthodontic Treatment

Syrian Arab Republic
University of Texas Southwestern Medical Center

Completed

Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) (DEEP)

Traumatic Brain Injury | Venous Thromboembolism

United States
Astellas Pharma Europe B.V.

Completed

A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery (ONYX-3)

Venous Thromboembolism | Arthroplasty, Replacement, Hip

Denmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
Sirtris, a GSK Company

Completed

A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers

Psoriasis

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Vanderbilt University Medical Center

Completed

Pragmatic Investigation of optimaL Oxygen Targets Trial (PILOT)

Respiratory Failure

United States
HaEmek Medical Center, Israel

Completed

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Thromboembolism | Preeclampsia | Fetal Demise | Abruptio Placentae | Fetal Growth Restriction

Israel
Sanofi

Completed

Enoxaparin in Acute Venous Thromboembolic Disease

Venous Thrombosis

Turkey
Medical University of Vienna

Completed

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

Cancer

Austria
Sanofi

Completed

Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)

Arthroplasty, Replacement, Hip

Japan
Frequency Therapeutics

Completed

FX-322 in Adults With Stable Sensorineural Hearing Loss

Sensorineural Hearing Loss | Noise Induced Hearing Loss | Sudden Sensorineural Hearing Loss

United States
King Abdullah International Medical Research Center

Completed

Efficacy and Safety for Different Regimen of VTE Pharmacoprophylaxis Among Severely Burn Patients

Burns

Saudi Arabia
Scripps Health

Completed

Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Deep Vein Thrombosis | Pulmonary Embolism | Venous Thromboembolic Disease

United States
University Hospital, Strasbourg, France

Terminated

Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women

Oxidative Stress | Gestational Diabetes | Treatment | Metformin

France
Boehringer Ingelheim

Terminated

Dabigatran Etexilate in Patients With Mechanical Heart Valves (RE-ALIGN)

Heart Valve Diseases

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland, Sweden
Boehringer Ingelheim

Terminated

Follow on Study From RE-ALIGN

Thromboembolism | Heart Valve Prosthesis

Belgium, Canada, Czech Republic, Denmark, France, Germany, Netherlands, Norway, Poland
Loyola University

Withdrawn

Timing of VTE Prophylaxis in TBI

TBI (Traumatic Brain Injury) | VTE (Venous Thromboembolism)

United States
Boehringer Ingelheim

Completed

A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting (ASSENT 3 Plus)

Myocardial Infarction
Astellas Pharma Inc

Completed

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement (PEARL-1)

Thromboembolism

Singapore, Indonesia, Japan, Korea, Republic of, Malaysia, Philippines, Taiwan, Thailand
Johns Hopkins All Children's Hospital

Completed

COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

COVID-19 | Thromboses, Venous | Infection Viral

United States
GlaxoSmithKline

Completed

ARIXTRA Local Study For Registration In China.

Thromboembolism | Knee Replacement | Hip Replacement

China
Boehringer Ingelheim

Completed

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

Thromboembolism | Arthroplasty, Replacement, Knee

United States, Canada, Mexico, United Kingdom
Zagazig University

Not yet recruiting

Low-Dose Enoxaparin in Psoriasis

Psoriasis
Western Galilee Hospital-Nahariya

Completed

Enoxaparin as Treatment for Vulvodynia

Vulvodynia

Israel
Sanofi

Completed

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Hip Fractures

Japan
Eli Lilly and Company

Completed

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Total Hip Replacement | Total Knee Replacement

Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Italy, Poland
The First Affiliated Hospital of University of...

Recruiting

A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy

Pancreatic Cancer | Common Bile Duct Diseases | Periampullary Carcinoma

China
Mashhad University of Medical Sciences

Unknown

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Esophageal Neoplasms

Iran, Islamic Republic of
Sanofi

Completed

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Abdominal Neoplasms

Japan
Norwegian University of Science and Technology

Completed

Effect of Discharge Via an Intermediate Care Unit

Aged | Patients

Norway
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Unknown

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Chronic Hepatitis b
Boehringer Ingelheim

Completed

Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI) (ASSENT 3)

Myocardial Infarction
Wake Forest University Health Sciences

Terminated

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Surgery | Regional Anesthesia Morbidity | Anticoagulants and Bleeding Disorders

United States
Perosphere Pharmaceuticals Inc, a wholly owned...

Completed

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin (PER977)

Healthy

United States
Sanofi

Completed

Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)

Percutaneous Coronary Intervention
Azidus Brasil

Completed

Safety Evaluation of Use Sodic Enoxaparin (Enoxaparin)

Kidney Disease

Brazil
Medical University of South Carolina

Completed

Weekly Isotretinoin Therapy Study (WIT)

Acne Vulgaris

United States
National Guard Health Affairs

Suspended

Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients (Lovenox)

Malignant Female Reproductive System Neoplasm

Saudi Arabia
Northwestern University
National Cancer Institute (NCI)

Completed

Heparin or Enoxaparin in Patients With Cancer

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific | Thromboembolism

United States
Sanofi

Completed

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Acute Ischemic Stroke

Korea, Republic of, Italy, Brazil, Canada, Colombia, Israel, Mexico, Poland, Czech Republic, United States, Australia, Austria, India, South Africa, Turkey
University of Zurich
University Hospital, Geneva; University Hospital Inselspital, Berne; University... and other collaborators

Terminated

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

COVID-19 | Pulmonary Embolism, Deep Vein Thrombosis

Switzerland, Germany
Intermountain Health Care, Inc.

Unknown

Weight Based Enoxaparin in Trauma Patients (WeBET)

Venous Thromboembolism

United States
CONKO-Studiengruppe

Completed

Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer

Pancreatic Cancer

Germany
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1972

Healthy

Belgium
Accuray Incorporated

Completed

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Prostatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic Cancer

United States
University Hospital, Caen
Centre Francois Baclesse

Unknown

Effect of Cervical Block on Recurrent Laryngeal Nerve Monitoring During Thyroid Surgery (THYRODOUL2)

Thyroid Surgery

France
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Bleeding as Surgical Complication (Treatment)
Chemi S.p.A.

Completed

A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions

Clexane is Administered to Healthy Volunteers

United Kingdom
Mohamed Sayed Abdelhafez

Completed

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Recurrent Miscarriage | Antiphospholipid Syndrome

Egypt
St. Olavs Hospital
Karolinska University Hospital; University Hospital of North Norway; Norwegian...

Completed

A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery

Meningioma

Norway, Sweden

Search clinical trials for: Intermediate dose enoxaparin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations